CBIZ Investment Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
CBIZ Investment Advisory Services's PFE Position: Q1 2026 in Review
CBIZ Investment Advisory Services reduced its Pfizer (PFE) stake by 82% in Q1 2026, selling an estimated $35.6K and leaving 303 shares worth $8.52K. The position accounts for ﹤0.01% of the portfolio, ranked #173.
CBIZ Investment Advisory Services first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $54.8K in Q2 2025. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- CBIZ Investment Advisory Services held 303 shares of Pfizer worth $8.52K as of Q1 2026.
- CBIZ Investment Advisory Services sold 1,336 Pfizer shares in Q1 2026, an estimated $35.6K.
- Pfizer made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #173 holding.
- CBIZ Investment Advisory Services first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
- CBIZ Investment Advisory Services's Pfizer position peaked at $54.8K in Q2 2025.
- 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.